Search

Memorial Sloan Kettering Cancer Center (MSK) has named William F. Pirl, MD, MPH, as the new Chair of the Psychiatry & Behavioral Sciences Department. Dr. Pirl is a nationally and internationally recognized expert and leader in psycho-oncology. He is no stranger to MSK; he completed his fellowship in psycho-oncology at the institution twenty-five years ago.

Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto.

Memorial Sloan Kettering Cancer Center (MSK) recently executed a contract with HealthLinx, a consulting firm that helps hundreds of hospitals achieve Magnet® and Pathway to Excellence ® designation. Under the agreement, MSK’s EBP Consulting Service will provide training in MSK’s proprietary evidence-based practice (EBP) methodology directly to select HealthLinx clients who are looking to improve or enculturate EBP.

Babies who are born with severe combined immunodeficiency can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering’s Richard O’Reilly.

A team of Memorial Sloan Kettering investigators has reported for the first time a novel strategy to coax human embryonic stem cells (HESCs) to develop into cells that could potentially be used to repair the musculoskeletal system, including bone, cartilage, and muscle.

When comparing options for immediate breast reconstruction after mastectomy, cost analyses should include patient-reported outcome (PRO) measures, such as BREAST-Q scales and complication rates.

NYC for MSK will unite New Yorkers and some of the most iconic New York brands to commemorate Memorial Sloan Kettering Cancer Center’s 140th Anniversary.

The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.